Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

OVERLAP
33%
OVERLAP
BY WEIGHT
10
# OF OVERLAPPING
HOLDINGS
PJP
29
HOLDINGS
34%
ALSO IN MEDX
MEDX
28
HOLDINGS
36%
ALSO IN PJP
SECTOR DRIFT (PJP minus MEDX)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in PJP |
Weight in MEDX |
Overlap | |
---|---|---|---|---|
JOHNSON & JOHNSON | 5.1% | 5.0% | 5.0% | |
ABBVIE INC | 4.9% | 9.4% | 4.9% | |
ELI LILLY & CO | 4.3% | 13.9% | 4.3% | |
AMGEN INC | 4.7% | 4.0% | 4.0% | |
PFIZER INC | 4.7% | 3.9% | 3.9% |
PJP Overweight Relative to MEDX
GILEAD SCIENCES INC | 4.8% | |
OCULAR THERAPEUTIX INC | 4.4% | |
ABBOTT LABORATORIES | 4.4% | |
BIOSANTE PHARMACEUTICALS INC | 3.6% | |
LIGAND PHARMACEUTICALS-CL B | 3.6% | |
SUPERNUS PHARMACEUTICALS INC | 3.2% | |
AMNEAL PHARMACEUTICALS, INC. CLASS A | 3.1% | |
TARSUS PHARMACEUTICALS, INC. | 3.1% | |
COLLEGIUM PHARMACEUTICAL, INC. | 3.1% | |
TRAVERE THERAPEUTICS, INC. | 2.9% |
PJP Underweight Relative to MEDX
ELI LILLY & CO | -9.7% | |
NOVARTIS AG-ADR | -7.1% | |
ALNYLAM PHARMACEUTICALS INC | -6.6% | |
ASTRAZENECA PLC-SPONS ADR | -5.4% | |
ABBVIE INC | -4.5% | |
ALKERMES PLC | -4.0% | |
CRISPR THERAPEUTICS AG | -3.3% | |
IONIS PHARMACEUTICALS, INC. | -3.1% | |
GLAXOSMITHKLINE PLC-SPON ADR | -2.6% | |
BRISTOL-MYERS SQUIBB CO | -2.2% |